In This Article:
Synthomer (LON:SYNT) Full Year 2024 Results
Key Financial Results
-
Revenue: UK£1.99b (flat on FY 2023).
-
Net loss: UK£70.0m (loss narrowed by 32% from FY 2023).
-
UK£0.43 loss per share (improved from UK£1.20 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Synthomer EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%.
Looking ahead, revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.0% decline forecast for the Chemicals industry in the United Kingdom.
Performance of the British Chemicals industry.
The company's shares are up 12% from a week ago.
Risk Analysis
We should say that we've discovered 2 warning signs for Synthomer (1 shouldn't be ignored!) that you should be aware of before investing here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.